As Nova Scotia’s life sciences sector has grown and evolved, BioNova has grown along with it, and we felt it was time to reflect that growth. In the last year we’ve experienced a lot of changes with the implementation of BioNova’s Growth Plan and will continue to see changes as we move towards building a bigger and better ecosystem to grow the life sciences in Nova Scotia. When we made these changes, we realized that our brand elements didn’t express us quite as well as they used to. It was time for a brand refresh to reflect who we are today and to symbolize our dynamic future. We will be discussing our next steps and opportunities for growth for BioNova and for the sector at BioPort Atlantic in two weeks time on October 25-26. If you haven’t already registered yet, I encourage you to do so as these are discussions you will not want to miss! In the upcoming months we have to update all of our collaterals, marketing literature, online presence, etc. with our new logo. We are aware that changing a logo is a process that can involve many steps and takes time. We will do our best to reach out to everyone who uses BioNova’s logo in any marketing materials but please contact our marketing officer, Emma Menchefski for the new logo and guidelines if you plan to update any of these materials in the near future. All the best, Scott Moffitt Managing Director]]>
BIONOVA CONTACT
#46 1344 Summer Street
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]

Recent Posts
- NEWS RELEASE: Doris Grant appointed Vice President Business Development and Strategy at BioNova
- MARS VR Lab
- Workinsights
- NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021
- NEWS RELEASE: BioNova’s BioPort 2021 Conference for Health and Life Sciences Kicks-Off Today
Business Wire National BioTech News
- New Microbiology and Chemistry Laboratory Gets Accredited under ISO/IEC 17025:2017
- Alpha Cancer Technologies Presents New Data from ACT-903, an AFP-Maytansine Conjugate, in Online Publication at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
- Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System
- LinusBio Bucks Market Slowdown, Secures Additional $8M in A2 Funding with Increased Valuation
- Cybin Announces US$30M Common Stock Purchase Agreement from Lincoln Park Capital Fund
- Alpha Cognition Announces First Quarter 2023 Results and Provides Corporate Update
- Alpha Cognition Launches $6.5 Million Private Placement
- IPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems Biology
- Enveric Biosciences Announces Poster Presentation at Canadian Neuroscience Meeting 2023
- BRUKINSA® Approved in Canada for the Treatment of Chronic Lymphocytic Leukemia
RECENT NEWS
- NEWS RELEASE: Doris Grant appointed Vice President Business Development and Strategy at BioNova February 9, 2023
- MARS VR Lab January 25, 2022
- Workinsights January 25, 2022
- NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021 November 8, 2021
- NEWS RELEASE: BioNova’s BioPort 2021 Conference for Health and Life Sciences Kicks-Off Today November 2, 2021
- NEWS RELEASE: BioNova Selects Eight Semi-Finalists to Participate in the 11th Annual BioInnovation Challenge August 24, 2021